431 related articles for article (PubMed ID: 11456453)
41. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
[TBL] [Abstract][Full Text] [Related]
42. Smad2 decelerates re-epithelialization during gingival wound healing.
Tomikawa K; Yamamoto T; Shiomi N; Shimoe M; Hongo S; Yamashiro K; Yamaguchi T; Maeda H; Takashiba S
J Dent Res; 2012 Aug; 91(8):764-70. PubMed ID: 22699208
[TBL] [Abstract][Full Text] [Related]
43. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.
Kel JM; Girard-Madoux MJ; Reizis B; Clausen BE
J Immunol; 2010 Sep; 185(6):3248-55. PubMed ID: 20713882
[TBL] [Abstract][Full Text] [Related]
44. Ectopic expression of the nude gene induces hyperproliferation and defects in differentiation: implications for the self-renewal of cutaneous epithelia.
Prowse DM; Lee D; Weiner L; Jiang N; Magro CM; Baden HP; Brissette JL
Dev Biol; 1999 Aug; 212(1):54-67. PubMed ID: 10419685
[TBL] [Abstract][Full Text] [Related]
45. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
46. Bioluminescence analysis of Smad-dependent TGF-beta signaling in live mice.
Luo J; Wyss-Coray T
Methods Mol Biol; 2009; 574():193-202. PubMed ID: 19685310
[TBL] [Abstract][Full Text] [Related]
47. Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis.
Zwijsen A; van Rooijen MA; Goumans MJ; Dewulf N; Bosman EA; ten Dijke P; Mummery CL; Huylebroeck D
Dev Dyn; 2000 Aug; 218(4):663-70. PubMed ID: 10906784
[TBL] [Abstract][Full Text] [Related]
48. An N-terminally truncated Smad2 protein can partially compensate for loss of full-length Smad2.
Das D; Randall RA; Hill CS
Biochem J; 2009 Jan; 417(1):205-12. PubMed ID: 18764783
[TBL] [Abstract][Full Text] [Related]
49. Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.
He W; Cao T; Smith DA; Myers TE; Wang XJ
Oncogene; 2001 Jan; 20(4):471-83. PubMed ID: 11313978
[TBL] [Abstract][Full Text] [Related]
50. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
[TBL] [Abstract][Full Text] [Related]
51. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
52. Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.
Shimizu A; Kato M; Nakao A; Imamura T; ten Dijke P; Heldin CH; Kawabata M; Shimada S; Miyazono K
Genes Cells; 1998 Feb; 3(2):125-34. PubMed ID: 9605406
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen.
Karatsaidis A; Schreurs O; Axéll T; Helgeland K; Schenck K
J Invest Dermatol; 2003 Dec; 121(6):1283-90. PubMed ID: 14675171
[TBL] [Abstract][Full Text] [Related]
54. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
55. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
Kato Y; Habas R; Katsuyama Y; Näär AM; He X
Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
[TBL] [Abstract][Full Text] [Related]
56. Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis.
Akhurst RJ; Fee F; Balmain A
Nature; 1988 Jan; 331(6154):363-5. PubMed ID: 3422343
[TBL] [Abstract][Full Text] [Related]
57. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
58. Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling.
Lin HY; Yang LT
Dev Biol; 2013 Jan; 373(2):394-406. PubMed ID: 23103542
[TBL] [Abstract][Full Text] [Related]
59. Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.
Xie W; Bharathy S; Kim D; Haffty BG; Rimm DL; Reiss M
Oncol Res; 2003; 14(2):61-73. PubMed ID: 14649540
[TBL] [Abstract][Full Text] [Related]
60. Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
Xie W; Wu X; Chow LT; Chin E; Paterson AJ; Kudlow JE
Cell Growth Differ; 1998 Apr; 9(4):313-25. PubMed ID: 9563851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
